Activity of the A3 adenosine receptor gene promoter in transgenic mice: Characterization of previously unidentified sites of expression

FEBS Letters

Volumn 532, Issue 3, 2002, Pages 267-272

  Yaar, Ron ^a   Lamperti, Edward D ^a   Toselli, Paul A ^a   Ravid, Katya ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; Nucleic acid regulatory sequence; Purinergic P1 receptor; Reporter gene

Indexed keywords

ADENOSINE A3 RECEPTOR; BETA GALACTOSIDASE;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENE LOCATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RETINA GANGLION CELL; SMOOTH MUSCLE FIBER; TESTIS; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION SITE; TRANSGENIC MOUSE;

ANIMALS; BETA-GALACTOSIDASE; BRAIN; FEMALE; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; LAC OPERON; MALE; MICE; MICE, TRANSGENIC; MODELS, GENETIC; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTIS; TRANSGENES;

MUS MUSCULUS;

EID: 0037132548     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(02)03612-8     Document Type: Article

References (28)

1. Olah M.E., Stiles G.L. Annu. Rev. Pharmacol. Toxicol. 35:1995;581-606.
2. Brambilla R., et al. Naunyn-Schmiedebergs Arch. Pharmacol. 361:2000;225-234.
3. Guo Y., et al. J. Mol. Cell. Cardiol. 33:2001;825-830.
4. Walker B.A., Jacobson M.A., Knight D.A., Salvatore C.A., Weir T., Zhou D., Bai T.R. Am. J. Respir. Cell Mol. Biol. 16:1997;531-537.
5. Salvatore C.A., Tilley S.L., Latour A.M., Fletcher D.S., Koller B.H., Jacobson M.A. J. Biol. Chem. 275:2000;4429-4434.
6. Salvatore C.A., Jacobson M.A., Taylor H.E., Linden J., Johnson R.G. Proc. Natl. Acad. Sci. USA. 90:1993;10365-10369.
7. Sajjadi F.G., Firestein G.S. Biochim. Biophys. Acta. 1179:1993;105-107.
8. Murrison E.M., Goodson S.J., Edbrooke M.R., Harris C.A. FEBS Lett. 384:1996;243-246.
9. Zhou Q.Y., Li C., Olah M.E., Johnson R.A., Stiles G.L., Civelli O. Proc. Natl. Acad. Sci. USA. 89:1992;7432-7436.
10. Sajjadi F.G., Boyle D.L., Domingo R.C., Firestein G.S. FEBS Lett. 382:1996;125-129.
11. Meyerhof W., Muller-Brechlin R., Richter D. FEBS Lett. 284:1991;155-160.
12. Dixon A.K., Gubitz A.K., Sirinathsinghji D.J., Richardson P.J., Freeman T.C. Br. J. Pharmacol. 118:1996;1461-1468.
13. Zhao Z., Francis C., Ravid K. Genomics. 57:1999;152-155.
14. Ravid K., Beeler D.L., Rabin M.S., Ruley H.E., Rosenberg R.D. Proc. Natl. Acad. Sci. USA. 88:1991;1521-1525.
15. Zimmet J.M., Ladd D., Jackson C.W., Stenberg P.E., Ravid K. Mol. Cell. Biol. 17:1997;7248-7259.
16. Yaar R., Cataldo L.M., Tzatsos A., Francis C.E., Zhao Z., Ravid K. Mol. Pharmacol. 62:2002;1167-1176.
17. Tolentino P.J., Dikkes P., Tsuruda L., Ebert K., Fink J.S., Villa-Komaroff L., Lamperti E.D. Mol. Brain Res. 33:1995;47-60.
18. Toselli P.A., Harbison G.R. Tissue Cell. 9:1977;137-156.
19. Zhao Z., Yaar R., Ladd D., Cataldo L.M., Ravid K. Microvasc. Res. 63:2002;61-69.
20. Avila M.Y., Stone R.A., Civan M.M. Br. J. Pharmacol. 134:2001;241-245.
21. Benowitz L.I., Jing Y., Tabibiazar R., Jo S.A., Petrausch B., Stuermer C.A., Rosenberg P.A., Irwin N. J. Biol. Chem. 273:1998;29626-29634.
22. Petrausch B., Tabibiazar R., Roser T., Jing Y., Goldman D., Stuermer C.A., Irwin N., Benowitz L.I. J. Neurosci. 20:2000;8031-8041.
23. Manabe I., Owens G.K. J. Biol. Chem. 276:2001;39076-39087.
24. Shanahan C.M., Weissberg P.L. Arterioscler. Thromb. Vasc. Biol. 18:1998;333-338.
25. Li S., Fan Y.S., Chow L.H., Van Den Diepstraten C., Van Der Veer E., Sims S.M., Pickering J.G. Circ. Res. 89:2001;517-525.
26. Min H.W., Moochhala S., Eng K.H. Life Sci. 66:2000;1781-1793.
27. Forghani R., et al. J. Neurosci. 21:2001;3780-3787.
28. Schlaeger T.M., Bartunkova S., Lawitts J.A., Teichmann G., Risau W., Deutsch U., Sato T.N. Proc. Natl. Acad. Sci. USA. 94:1997;3058-3063.